Eric L. Crowell

Eric L. Crowell

Auto-generated profile, based on publicly available information

Eric L. Crowell

The University of Texas at Austin

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 September 2023 in Ophthalmology Retina
Verified
Journal Article
Open access
RKReza Kianian
Reza Kianian
DSDeyu Sun
Deyu Sun
ECEric L. Crowell
Eric L. Crowell
ETEdmund Tsui
Edmund Tsui
To assess Large Language Models in generating readable uveitis information and in improving the readability of online health information. Evaluation of Technology. Not applicable. ChatGPT and Bard were asked the following prompts: Prompt A) "considering that the average American reads at a 6th grade level, using the Flesch-Kincaid Grade Level formula, can you write patient-targeted health information on uveitis of around 6th grade level?", and Prompt B) "can you write patient-targeted health information on uveitis that is easy to understand by an average American?". Additionally, ChatGPT and Bard were asked the following prompt from the first-page results of Google when the term "uveitis" was searched: "Considering that the average American reads at a 6th grade level, using the Flesch-Kincaid Grade level formula, can you rewrite the following text to 6th grade level: [insert text]". The readability of each response was analyzed and compared using several metrics described below. The Flesch Kincaid Grade Level (FKGL), is a highly validated readability assessment tool that assigns a grade level to a given text, the total number of words, sentences, syllables, and complex words. Complex words were defined as those with greater than 2 syllables. ChatGPT and Bard generated responses with lower FKGL scores (i.e. easier-to-understand) in response to Prompt A compared to Prompt B. This was only significant for ChatGPT (p<0.0001). The mean FKGL of responses to ChatGPT (6.3 ±1.2) was significantly lower (p<0.0001) than Bard 10.5 ± 0.8. ChatGPT responses also contained less complex words than Bard (p<0.0001). Online health information on uveitis had a mean grade level of 11.0 ± 0.8. ChatGPT lowered the FKGL to 8.0 ± 1.0 (p<0.0001) when asked to re-write the content. Bard was not able to do so (mean FKGL of 11.1 ±1.6). ChatGPT can aid clinicians in producing easier-to-understand health information on uveitis for patients compared to already-existing content. It can also help with reducing the difficulty of the language used for uveitis health information targeted for patients.

14 March 2022 in Ophthalmology Glaucoma
Verified
Journal Article
Closed access
CMCole A. Martin
Cole A. Martin
SKSaima Khan
Saima Khan
RLRachel Lee
Rachel Lee
ADAnna T. Do
Anna T. Do
JSJayanth Sridhar
Jayanth Sridhar
EBEileen Bowden
Eileen Bowden

6 June 2025 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
CJColeman Johnson
Coleman Johnson
BCBeibei Chen
Beibei Chen
ABAanya Bhalla
Aanya Bhalla
ECEric Crowell
Eric Crowell
FZFeng Zhang
Feng Zhang

1 January 2021 in Journal of Ophthalmology
Verified
Journal Article
Open access
PDF file
DCDalbert J. Chen
Dalbert J. Chen
JKJacky C. Kuo
Jacky C. Kuo
AWAlex J. Wright
Alex J. Wright
ACAlice Z. Chuang
Alice Z. Chuang
WCWenyaw Chan
Wenyaw Chan
ECEric L. Crowell
Eric L. Crowell
Purpose . To determine risk factors that affect nonproliferative diabetic retinopathy (NPDR) progression and establish a predictive model to estimate the probability of and time to progression in NPDR. Patients and Methods . Charts of diabetic patients who received an initial eye exam between 2010 and 2017 at our county hospital were included. Patients with proliferative diabetic retinopathy (PDR), fewer than 2 years of follow‐up, or fewer than 3 clinic visits were excluded. Demographics and baseline systemic and ocular characteristics were recorded. Follow‐up mean annual HbA1c and blood pressure, best‐corrected visual acuity, and the number of antivascular endothelial growth factor treatments were recorded. Stage and date of progression were recorded. A 5‐state nonhomogeneous continuous‐time Markov chain with a backward elimination model was used to identify risk factors and estimate their effects on progression. Results . Two hundred thirty patients were included. Initially, 65 eyes (28.3%) had no retinopathy; 73 (31.7%) mild NPDR; 60 (26.1%) moderate NPDR; and 32 (13.9%) severe NPDR. Patients were followed for a mean of 5.8 years (±2.0 years; range 2.1–9.4 years). 164 (71.3%) eyes progressed during the follow‐up. Time‐independent risk factors affecting progression rate were age (hazard ratio (HR) = 0.99, P = 0.047), duration of diabetes (HR = 1.02, P = 0.018), and Hispanic ethnicity (HR = 1.31, P = 0.068). Mean sojourn times at mean age, duration of diabetes, and annual HbA1c for a non‐Hispanic patient were estimated to be 3.03 (±0.97), 4.63 (±1.21), 6.18 (±1.45), and 4.85 (±1.25) years for no retinopathy, mild NPDR, moderate NPDR, and severe NPDR, respectively. Each 1% increase in HbA1c annually diminished sojourn times by 15%, 10%, 7%, and 10% for no retinopathy, mild NPDR, moderate NPDR, and severe NPDR, respectively. Conclusion . HbA1c level is a significant modifiable risk factor in controlling the progression of DR. The proposed model could be used to predict the time and rate of progression based on an individual’s risk factors. A prospective multicenter study should be conducted to further validate our model.

14 July 2023 in Journal of Academic Ophthalmology
Verified
Journal Article
Open access
PDF file
EWEvan K. Wotipka
Evan K. Wotipka
AWAlex J. Wright
Alex J. Wright
JFJames Z. Fan
James Z. Fan
DFDavid Fuhriman
David Fuhriman
ACAlice Z. Chuang
Alice Z. Chuang
ECEric L. Crowell
Eric L. Crowell
Purpose Compare postoperative outcomes in cataract surgery between eyes with standard drop regimen versus dropless protocol by residents. Design Retrospective cohort study between April 1, 2018 and March 31, 2020. Methods The study was performed at Lyndon B. Johnson General Hospital in Houston, Harris County, Texas. A total of 547 eyes (234 dropless vs. 313 standard) with phacoemulsification cataract surgery and minimum of 1-month follow-up with best-corrected visual acuity (BCVA) were included. Dropless received 40 mg sub-Tenon's triamcinolone and intracameral moxifloxacin. Patients were followed at postoperative day 1 (POD1), week 1 (POW1), and month 1 (POM1). Postoperative rate of BCVA better than 20/40 (Good vision) and rate of complications were compared between groups. Results Good vision on POM1 in dropless (77.8%) was noninferior to standard (75.1%, p = 0.80). Complication rate in dropless (28.6%) was noninferior to standard (24.0%, p = 0.13). Intraocular pressure (IOP) elevation on POD1 (p = 0.041) and anterior chamber (AC) cells on POW1 and POM1 (p < 0.001) were more frequent in dropless. Mean spherical equivalent at POM1 was better in dropless (−0.37 D [±0.81 D]) compared with standard (−0.61D [±0.77 D], p = 0.001). Early posterior capsular opacification (early PCO) was more frequent in dropless (p = 0.042). Conclusions Postoperative rate of BCVA better than 20/40 and rate of postoperative complications were noninferior, although dropless had higher rates of AC inflammation, IOP elevation, and early PCO.

26 November 2024 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
KSKaren Sun
Karen Sun
RMRayna Marshall
Rayna Marshall
MFMichael Frankland
Michael Frankland
ATAmal Taylor
Amal Taylor
CMCynthia Montana
Cynthia Montana
MBMeghan Berkenstock
Meghan Berkenstock
To evaluate the barriers to adherence with immunomodulatory therapy (IMT) for patients with uveitis across multiple regions of the United States. A multi-center survey of adult and pediatric patients with ocular inflammatory diseases undergoing treatment with IMT was conducted between September 2021 and August 2022. Participating sites included Johns Hopkins Wilmer Eye Institute, Wong Eye Institute of the University of Texas at Austin, University of Wisconsin-Madison, University of Minnesota, Veterans Affairs Hospital of Minneapolis, and Washington University of St. Louis. Each patient completed a self-reporting survey to identify barriers to adherence. The survey was completed by 98 subjects, of whom were 71% white, 67% female, and 61% had a college or advanced degree. Nearly half (49%) were on two or more IMTs of which the most common were methotrexate (38%), mycophenolate (36%), or adalimumab (36%). Nearly half (52%) of patients required reminders to take their medications and 20% found it difficult to take IMT regularly, with 12% struggling to take medications multiple times a day. A lack of refills resulted in 15% of patients missing doses. Limitations to completing laboratory studies to monitor for drug-related side-effects included finding time (10%) and cost (22%). Barriers to IMT treatment include laboratory study cost, difficulty with medication administration, and adhering to medication schedules. Monthly cost of medication was high for some, but no patients were unable to take IMT due to insurance loss. Addressing these barriers may improve IMT adherence for uveitis patients and better clinical outcomes.